- Home
- HUBCW vs BDTX Comparison
HUBCW vs BDTX Comparison
Compare HUBCW & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBCW
- BDTX
- Stock Information
- Founded
- HUBCW N/A
- BDTX 2014
- Country
- HUBCW Israel
- BDTX United States
- Employees
- HUBCW 322
- BDTX N/A
- Industry
- HUBCW
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUBCW
- BDTX Health Care
- Exchange
- HUBCW Nasdaq
- BDTX Nasdaq
- Market Cap
- HUBCW N/A
- BDTX 132.5M
- IPO Year
- HUBCW N/A
- BDTX 2020
- Fundamental
- Price
- HUBCW $0.02
- BDTX $2.95
- Analyst Decision
- HUBCW
- BDTX Strong Buy
- Analyst Count
- HUBCW 0
- BDTX 6
- Target Price
- HUBCW N/A
- BDTX $14.83
- AVG Volume (30 Days)
- HUBCW N/A
- BDTX 1.2M
- Earning Date
- HUBCW N/A
- BDTX 08-05-2025
- Dividend Yield
- HUBCW N/A
- BDTX N/A
- EPS Growth
- HUBCW N/A
- BDTX N/A
- EPS
- HUBCW N/A
- BDTX 0.09
- Revenue
- HUBCW N/A
- BDTX $70,000,000.00
- Revenue This Year
- HUBCW N/A
- BDTX N/A
- Revenue Next Year
- HUBCW N/A
- BDTX N/A
- P/E Ratio
- HUBCW N/A
- BDTX $33.54
- Revenue Growth
- HUBCW N/A
- BDTX N/A
- 52 Week Low
- HUBCW N/A
- BDTX $1.20
- 52 Week High
- HUBCW N/A
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- HUBCW N/A
- BDTX 71.02
- Support Level
- HUBCW N/A
- BDTX $2.43
- Resistance Level
- HUBCW N/A
- BDTX $2.72
- Average True Range (ATR)
- HUBCW 0.00
- BDTX 0.17
- MACD
- HUBCW 0.00
- BDTX 0.03
- Stochastic Oscillator
- HUBCW 0.00
- BDTX 93.85
About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.